IBA Launches myQA StarTrack³ to Streamline Radiation Therapy QA
Event summary
- IBA SA introduced myQA StarTrack³, a next-generation 2D ionization chamber array for linear accelerator (linac) quality assurance (QA) in radiation therapy.
- The device enables comprehensive beam QA with water tank accuracy using a single detector setup, reducing setup time to under five minutes.
- The solution includes a web-based software platform for centralized QA data management and real-time analysis.
- IBA will showcase myQA StarTrack³ at the ESTRO 2026 Annual Congress in Stockholm from May 15 to May 18, 2026.
The big picture
IBA’s launch of myQA StarTrack³ aligns with the broader trend of digitizing and automating quality assurance in radiation therapy. As radiotherapy techniques become more sophisticated, the demand for efficient, high-resolution QA solutions is growing. IBA’s move reinforces its leadership in dosimetry and particle accelerator technology, particularly in proton therapy, where precision and reliability are critical.
What we're watching
- Adoption Pace
- How quickly medical physics teams will integrate myQA StarTrack³ into their workflows, given its promise of efficiency gains.
- Competitive Response
- Whether competitors in the radiation therapy QA space will introduce similar single-detector solutions to match IBA’s offering.
- Regulatory Acceptance
- The extent to which regulatory bodies will endorse the device’s water tank-equivalent accuracy for standardized QA protocols.
Related topics